Literature DB >> 20587233

Endovascular treatment of acute embolism of the major cerebral arteries. The value of balloon disruption of the embolus.

S Ota1, T Ota, K Goto, I Inoue, T Ota.   

Abstract

SUMMARY: This study evaluated: 1) the effect of recanalization on changing clinical outcome, 2) the relationship between dose of Urokinase (UK) and incidence of recanalization and intracranial haemorrhage, and 3) the efficacy and feasibility of balloon disruption (BD) in the treatment of acute cerebral embolism. Sixty-one patients with acute embolism of the major cerebral arteries treated by endovascular approaches over the past nine years were retrospectively evaluated. Among them, 30 cases were treated by BD alone or in conjunction with intra- arterial fibrinolysis in the last five years. The other 31 cases, mostly treated in the first four years, were treated with intra-arterial fibrinolysis alone and were used as controls to evaluate the efficacy of BD. Control angiography was performed just after the reperfusion procedure to evaluate the degree of recanalization. Angiographic responses were graded using modified Thrombolysis in Myocardial Infarction (TIMI) criteria. Clinical outcome was evaluated using modified Rankin Scale (mRS) score at the time of discharge. Thirty-six of the 61 patients (59.0%) achieved high-grade recanalization (TIMI grade 3). Significantly more patients attained favorable outcome (mRS score 0-1) in the high-grade recanalization group than the low-grade recanalization group (41.7% vs. 16.0%, p < 0.05). Concerning patients treated with BD, significantly more patients attained good recanalization and significantly more patients were ambulatory (mRS score 0-3) than those treated with intra-arterial fibrinolysis alone (76.7% vs. 41.9%, p < 0.01; 70.0% vs. 41.9%, p < 0.05, respectively). A significantly lower dose of UK was used, and relatively less intracranial haemorrhage was seen in patients treated with BD than those treated with intra- arterial fibrinolysis (194,000 +/- 191,000 units vs. 388,000 +/- 231,000 units, p=0.001; 16.7% vs. 38.7%, p=0.055, respectively). Concerning morbidity and mortality of BD, there was one death caused by dissection of the M2 portion of the middle cerebral artery (MCA) that happened during BD on a distally migrated embolus. Although no conclusions can be drawn from our study, a favorable outcome for acute embolism of the major cerebral arteries is expected by attaining good recanalization. In addition, BD is an effective technique that can achieve high-grade recanalization alone, or reducing the dose of fibrinolytic agent.

Entities:  

Year:  2005        PMID: 20587233      PMCID: PMC3463250          DOI: 10.1177/159101990401000303

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  31 in total

1.  Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report.

Authors:  B W Chopko; C Kerber; W Wong; B Georgy
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

2.  Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis.

Authors:  Shinichi Nakano; Tsutomu Iseda; Takumi Yoneyama; Hirokazu Kawano; Shinichiro Wakisaka
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

3.  Mechanical intracranial embolectomy. A report of two cases.

Authors:  G Wikholm
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

4.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

5.  Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

Authors:  I L Katzan; A J Furlan; L E Lloyd; J I Frank; D L Harper; J A Hinchey; J P Hammel; A Qu; C A Sila
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

6.  Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections.

Authors:  Pedro Lylyk; José E Cohen; Rosana Ceratto; Angel Ferrario; Carlos Miranda
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Transarterial embolectomy in acute stroke.

Authors:  Gunnar Wikholm
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

9.  Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty.

Authors:  T Mori; M Fukuoka; K Kazita; K Mori
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

10.  Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries.

Authors:  R T Higashida; F Y Tsai; V V Halbach; C F Dowd; T Smith; K Fraser; G B Hieshima
Journal:  J Neurosurg       Date:  1993-02       Impact factor: 5.115

View more
  1 in total

1.  Mechanical revascularization of acute iatrogenic anterior cerebral artery occlusions: use of a new coaxial dual-lumen balloon catheter results in rapid access and flow restoration.

Authors:  Robert F James; John Richard Lamm; Hilal A Kanaan
Journal:  BMJ Case Rep       Date:  2012-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.